| |
| Magyar Immunológiai Társaság |
|
| Sejtek közötti és sejten belüli interakciók szerepe az immunválasz kialakításában és szabályozásában |
 Rendezvény kezdete: 2024.11.21. | Rendezvény vége: 2024.11.22. |
| Helyszín: Budapest, OMINT, Közösségi Központ, Lukács Épület, fszt. |
Helyszín: OMINT, Közösségi Központ, Lukács Épület, fszt.
Időpont: 2024.11.21-22. csütörtök-péntek
14 tanfolyami óra, 28 akkreditációs pont.
Szabadon választott tanfolyam: akkr. száma: SE-SZTOK/2024.II/00413
Szakképesítések, amelyekhez szakma szerinti pontszámként elszámolható:
1. allergológia és klinikai immunológia | 2. belgyógyászat | 3. immunológia (képesítés) | 4. labor. haemat. és immunológia | 5. molekuláris biológiai diagnosztikus | 6. reumatológia | 7. rezidensek és szakorvos jelöltek
Szakképzésként, szakvizsga előkészítő és rezidensek számára ajánlott: akkr. SE-SZTOK/2024.II/00416 számmal akkreditált tanfolyam
A program megtekinthető ide kattintva |
|
|
 |
| |
| Magyar Immunológiai Társaság |
|
| Cutaneous Lymphomas 2013 |
| Rendezvény kezdete: 2013.02.06. | Rendezvény vége: 2013.02.09. |
| Szervező: Annette Gleich |
| Munkahely neve: MCI Deutschland GmbH | MCI – Berlin Office |
| Címe: Markgrafenstrasse 56 | 10117 Berlin | Germany |
| Tel: +49 (0)30 20 45 90 |
| Fax: +49 (0)30 20 45 950 |
| E-mail: lymphomas2013@mci-group.com |
| Helyszín: Germany / Németország, Berlin, |
| A rendezvény Web oldala: http://www.cutaneouslymphomas2013.com/ |
2nd WCCL/6th ISBICL 2013
World Congress of Cutaneous Lymphomas (WCCL) and International Symposium on the Biology and Immunology of Cutaneous Lymphoma (ISBICL)
Dear colleagues,
Following the immensely successful 1st World Congress of Cutaneous Lymphomas (WCCL) in Chicago with its clinical emphasis and the 5th International Symposium on the Biology and Immunology of Cutaneous Lymphoma (ISBICL) with its focus on basic and translational research, we are most delighted to invite you to join us at the 2nd WCCL/6th ISBICL 2013 in Berlin. This unique meeting will review both the latest research and development relating to cutaneous lymphomas and the clinical practice including new therapies and clinical trials. The congress is supported by the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium and the EORTC Cutaneous Lymphoma Task Force.
In addition to a rewarding congress program, the visit to Berlin will bring you right into touch with the profound political changes of recent years and into one of the most vibrant cultural centers of the world with numerous concerts, operas, theaters, cabarets, museums, exhibitions, fairs and off-stage events. All who have visited the city before will be amazed of the rapid developments and will find ever new paths to explore.
We look forward to welcoming you in Berlin for a certainly most exciting congress and a rich personal experience.
Yours cordially
The International Program Committee
The Local Organizing Committee
Abstract submission deadline extended until December 14, 2012
|
|
|
|
| |
| Magyar Immunológiai Társaság |
|
| Cutaneous Lymphomas 2013 |
| Rendezvény kezdete: 2013.02.06. | Rendezvény vége: 2013.02.09. |
| Szervező: Annette Gleich |
| Munkahely neve: MCI Deutschland GmbH | MCI – Berlin Office |
| Címe: Markgrafenstrasse 56 | 10117 Berlin | Germany |
| Tel: +49 (0)30 20 45 90 |
| Fax: +49 (0)30 20 45 950 |
| E-mail: lymphomas2013@mci-group.com |
| Helyszín: Germany / Németország, Berlin, |
| A rendezvény Web oldala: http://www.cutaneouslymphomas2013.com/ |
2nd WCCL/6th ISBICL 2013
World Congress of Cutaneous Lymphomas (WCCL) and International Symposium on the Biology and Immunology of Cutaneous Lymphoma (ISBICL)
Dear colleagues,
Following the immensely successful 1st World Congress of Cutaneous Lymphomas (WCCL) in Chicago with its clinical emphasis and the 5th International Symposium on the Biology and Immunology of Cutaneous Lymphoma (ISBICL) with its focus on basic and translational research, we are most delighted to invite you to join us at the 2nd WCCL/6th ISBICL 2013 in Berlin. This unique meeting will review both the latest research and development relating to cutaneous lymphomas and the clinical practice including new therapies and clinical trials. The congress is supported by the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium and the EORTC Cutaneous Lymphoma Task Force.
In addition to a rewarding congress program, the visit to Berlin will bring you right into touch with the profound political changes of recent years and into one of the most vibrant cultural centers of the world with numerous concerts, operas, theaters, cabarets, museums, exhibitions, fairs and off-stage events. All who have visited the city before will be amazed of the rapid developments and will find ever new paths to explore.
We look forward to welcoming you in Berlin for a certainly most exciting congress and a rich personal experience.
Yours cordially
The International Program Committee
The Local Organizing Committee
Abstract submission deadline extended until December 14, 2012
|
|
|
|
| |
| Magyar Diabetes Társaság |
|
| The 2nd International Conference on Prehypertension and Cardio Metabolic Syndrome |
| Rendezvény kezdete: 2013.01.31. | Rendezvény vége: 2013.02.03. |
| Szakterület(ek): Belgyógyászat |
| Munkahely neve: Paragon Conventions |
| Tel: +41 22 533 0948 |
| Fax: +41 22 580 2953 |
| E-mail: secretariat@prehypertension.org |
| Helyszín: Spanyolország, 08028 Barcelona, Av. Diagonal 661-671, Hotel Rey Juan Carlos I - Business & City Resort |
| A rendezvény Web oldala: http://www.prehypertension.org/ |
List of Topics
• Metabolic Syndrome and Vitamin D
• Prediabetes - Mechanisms, Diagnosis and Management
• Pre Levels of CV Risk Factors - Boosting Risk of Events and Deciding Who Should be Treated
• Benefits of Achieving Optimal Risk Factors Level - When, How and with What?
• Prehypertension and Metabolic Syndrome in Different Populations - Epidemiologic Aspects
• Total Cardiovascular Risk Evaluation and Management
• Arterial Properties, Evaluation and Treatment in Metabolic Syndrome
• Cardiac Markers of Preclinical Disease in Metabolic Syndrome Patients
• Effect of Pre Disease Risk Factors in Patients with the Metabolic Syndrome on Morbidity and Mortality
• Which Elderly Patients with Pre Disease should be Considered for Medical Treatment
• Children and Adolescents: Prehypertension and Metabolic Syndrome, Progression of Risk and Diagnosis of Disease
• The Heart, the Brain and the Kidney in Pre Disease and the Metabolic Syndrome
• Addressing the Global CV Risk Factors in Pre Disease and in Disease
• Arterial Properties, Central Blood Pressure and Augmentation Index in Pre Disease and Disease in Patients with Cardiometabolic Syndrome
• Prehypertension, Hypertension and Renal Denervation
• Prehypertension, Pre Diabetes and Dyslipidemia - Estimation of Risk and Therapeutic Approach
Important DatesDeadline for submission of abstracts: September 13, 2012
Deadline for early bird registration: October 15, 2012
Deadline for pre-conference registration: January 22, 2013 |
|
|
|
